Drug Patent Watch

FEBRUARY 2, 2021

In their coverage of Mark Cuban’s new pharma company, they cited our published interview where Mark Cuban Sounds off on Drug Prices.…. The post DrugPatentWatch featured in Inc Magazine appeared first on DrugPatentWatch - Make Better Decisions. DrugPatentWatch was featured in a recent article by Inc.

Drug Pricing 103

Drug Pricing 103

pharmaphorum

MAY 14, 2021

This article appears in our digital magazine, Deep Dive: Market Access 2021. Long headquartered in London, the EU drug regulator is now severed from the country both physically and systematically, with its base now in Amsterdam and the UK now assessing drugs through its own regulatory agency, MHRA. appeared first on.

Drug Pricing 59

Drug Pricing Documentation Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

FEBRUARY 18, 2021

Drug prices to plummet in wave of expiring patents”. Price decay after loss of brand exclusivity”. These are just three headlines that come up when you Google “drug patent expiry”. AstraZeneca’s patent for its top-selling gastroesophageal reflux disease drug was due to expire in 2001.

Prescription Filling 52

Prescription Filling Drug Pricing Biosimilars Compounding 52

pharmaphorum

JULY 26, 2021

Healthcare systems and patients are suffering the consequences, as drug prices and times to market increase, and access to treatments is consequently hindered in the context of an ageing population carrying an ever-rising chronic disease burden. Indeed, increasing costs pose pharma’s biggest R&D challenge today.

Drug Pricing 52

Drug Pricing Drug Development 52

Pharmaceutical Technology

SEPTEMBER 20, 2024

In this issue: Solving adherence issues with prodrugs, examining whether PBMs are to blame for high drugs prices in the US, developing vaccines for Disease X, and more.

Drug Pricing 52

Drug Pricing Vaccines 52